Creative Planning’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $623K | Buy |
177,520
+15,445
| +10% | +$63.3K | ﹤0.01% | 2854 |
|
|
2025
Q4 | $546K | Buy |
162,075
+71,919
| +80% | +$187K | ﹤0.01% | 2765 |
|
|
2025
Q3 | $118K | Sell |
90,156
-3,524
| -4% | -$3.65K | ﹤0.01% | 3649 |
|
|
2025
Q2 | $67.2K | Buy |
93,680
+9,048
| +11% | +$7.1K | ﹤0.01% | 3487 |
|
|
2025
Q1 | $124K | Sell |
84,632
-18,918
| -18% | -$45.1K | ﹤0.01% | 3208 |
|
|
2024
Q4 | $459K | Buy |
103,550
+61,399
| +146% | +$249K | ﹤0.01% | 2306 |
|
|
2024
Q3 | $174K | Buy |
42,151
+4,749
| +13% | +$25.5K | ﹤0.01% | 2887 |
|
|
2024
Q2 | $244K | Sell |
37,402
-12,197
| -25% | -$86.3K | ﹤0.01% | 2519 |
|
|
2024
Q1 | $432K | Sell |
49,599
-40,857
| -45% | -$496K | ﹤0.01% | 1957 |
|
|
2023
Q4 | $1.03M | Buy |
90,456
+22,377
| +33% | +$221K | ﹤0.01% | 1211 |
|
|
2023
Q3 | $656K | Sell |
68,079
-4,575
| -6% | -$44.8K | ﹤0.01% | 1385 |
|
|
2023
Q2 | $773K | Buy |
72,654
+5,675
| +8% | +$61K | ﹤0.01% | 1268 |
|
|
2023
Q1 | $705K | Buy |
66,979
+9,632
| +17% | +$108K | ﹤0.01% | 1275 |
|
|
2022
Q4 | $711K | Buy |
57,347
+28,163
| +97% | +$319K | ﹤0.01% | 1220 |
|
|
2022
Q3 | $302K | Buy |
29,184
+2,726
| +10% | +$30.9K | ﹤0.01% | 1640 |
|
|
2022
Q2 | $305K | Hold |
26,458
| – | – | ﹤0.01% | 1598 |
|
|
2022
Q1 | $333K | Hold |
26,458
| – | – | ﹤0.01% | 1560 |
|
|
2021
Q4 | $309K | Hold |
26,458
| – | – | ﹤0.01% | 1601 |
|
|
2021
Q3 | $346K | Sell |
26,458
-77,845
| -75% | -$1.01M | ﹤0.01% | 1507 |
|
|
2021
Q2 | $1.34M | Buy |
+104,303
| New | +$1.19M | ﹤0.01% | 814 |
|
|
2017
Q3 | – | Sell |
-205
| Closed | -$3K | – | 2789 |
|
|
2017
Q2 | $3K | Sell |
205
-34
| -14% | -$494 | ﹤0.01% | 4185 |
|
|
2017
Q1 | $3K | Buy |
+239
| New | +$3.27K | ﹤0.01% | 4164 |
|
|
2016
Q2 | – | Sell |
-6,155
| Closed | -$56K | – | 4430 |
|
|
2016
Q1 | $56K | Hold |
6,155
| – | – | ﹤0.01% | 2018 |
|
|
2015
Q4 | $60K | Hold |
6,155
| – | – | ﹤0.01% | 1969 |
|
|
2015
Q3 | $54K | Buy |
+6,155
| New | +$57.4K | ﹤0.01% | 1987 |
|
|
2015
Q2 | – | Sell |
-6,155
| Closed | -$82K | – | 2029 |
|
|
2015
Q1 | $82K | Sell |
6,155
-2,051
| -25% | -$26.9K | ﹤0.01% | 1685 |
|
|
2014
Q4 | $105K | Hold |
8,206
| – | – | ﹤0.01% | 1526 |
|
|
2014
Q3 | $89K | Hold |
8,206
| – | – | ﹤0.01% | 1550 |
|
|
2014
Q2 | $105K | Hold |
8,206
| – | – | ﹤0.01% | 1402 |
|
|
2014
Q1 | $85K | Sell |
8,206
-2,099
| -20% | -$23.6K | ﹤0.01% | 1502 |
|
|
2013
Q4 | $100K | Hold |
10,305
| – | – | ﹤0.01% | 1195 |
|
|
2013
Q3 | $102K | Hold |
10,305
| – | – | ﹤0.01% | 1106 |
|
|
2013
Q2 | $86K | Buy |
+10,305
| New | +$125K | ﹤0.01% | 1068 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Creative Planning's IRWD Position: Q1 2026 in Review
Creative Planning increased its Ironwood Pharmaceuticals (IRWD) stake by 9.5% in Q1 2026, buying an estimated $63.3K and bringing the position to 177,520 shares worth $623K. The position accounts for ﹤0.01% of the portfolio, ranked #2854.
Creative Planning first reported a position in IRWD in Q2 2013 and has held it in 33 quarters since. The position peaked at $1.34M in Q2 2021. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Creative Planning held 177,520 shares of Ironwood Pharmaceuticals worth $623K as of Q1 2026.
- Creative Planning bought 15,445 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $63.3K.
- Ironwood Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #2854 holding.
- Creative Planning first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 33 quarters since.
- Creative Planning's Ironwood Pharmaceuticals position peaked at $1.34M in Q2 2021.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.